Abimbola O. Famuyide

Abimbola O. Famuyide

Auto-generated profile, based on publicly available information

Abimbola O. Famuyide

Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
YTYvonne S. Butler Tobah
Yvonne S. Butler Tobah
ALAnnie LeBlanc
Annie LeBlanc
MBMegan E. Branda
Megan E. Branda
JIJonathan W. Inselman
Jonathan W. Inselman
MMMegan A. Morris
Megan A. Morris
AFAbimbola Famuyide
Abimbola Famuyide

1 August 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
SSSherif A.M. Shazly
Sherif A.M. Shazly
MMMohammad H. Murad
Mohammad H. Murad
SDSean C. Dowdy
Sean C. Dowdy
BGBobbie S. Gostout
Bobbie S. Gostout
AFAbimbola O. Famuyide
Abimbola O. Famuyide

1 November 2015 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
MTMary Catherine Tolcher
Mary Catherine Tolcher
MHMichael R. Holbert
Michael R. Holbert
AWAmy L. Weaver
Amy L. Weaver
MMMichaela E. BS McGree
Michaela E. BS McGree
JOJanet E. Olson
Janet E. Olson
BBBrian C. Brost
Brian C. Brost
OBJECTIVE: To identify independent risk factors for cesarean delivery after induction of labor and to develop a nomogram for predicting cesarean delivery among nulliparous women undergoing induction of labor at term. METHODS: This is a retrospective cohort study including nulliparous women with singleton, term (37 0/7 weeks of gestation or greater), cephalic pregnancies undergoing induction of labor from July 1, 2006, through May 31, 2012, at a tertiary care academic center. Inductions were identified using International Classification of Diseases, 9th Revision codes. Demographic, delivery, and outcome data were abstracted manually from the medical record. Women with a contraindication to vaginal delivery (malpresentation, abnormal placentation, prior myomectomy) were excluded. Independent risk factors for cesarean delivery were identified using logistic regression. RESULTS: During the study period, there were 785 nulliparous inductions that met study criteria; 231 (29.4%) underwent cesarean delivery. Independent risk factors associated with an increased risk of cesarean delivery included older maternal age, shorter maternal height, greater body mass index, greater weight gain during pregnancy, older gestational age, hypertension, diabetes mellitus, and initial cervical dilation less than 3 cm. A nomogram was constructed based on the final model with a bias-corrected c-index of 0.709 (95% confidence interval 0.671–0.750). CONCLUSION: We identified independent risk factors that can be used to predict cesarean delivery among nulliparous women undergoing induction of labor at term. If validated in other populations, the nomogram could be useful for individualized counseling of women with a combination of identifiable antepartum risk factors. LEVEL OF EVIDENCE: II

1 January 2009 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
SESherif A. Mbbch El-Nashar
Sherif A. Mbbch El-Nashar
MHMatthew R. Hopkins
Matthew R. Hopkins
DCDouglas J. Creedon
Douglas J. Creedon
JSJennifer L. St. Sauver
Jennifer L. St. Sauver
AWAmy L. Weaver
Amy L. Weaver
AFAbimbola O. Mbbs Famuyide
Abimbola O. Mbbs Famuyide
OBJECTIVE: To report rates of amenorrhea and treatment failure after global endometrial ablation and to estimate the association between patient factors and these outcomes by developing and validating prediction models. METHODS: From January 1998 through December 2005, 816 women underwent global endometrial ablation with either a thermal balloon ablation or radio frequency ablation device; 455 were included in a population-derived cohort (for model development), and 361 were included in a referral-derived cohort (for model validation). Amenorrhea was defined as cessation of bleeding from immediately after ablation through at least 12 months after the procedure. Treatment failure was defined as hysterectomy or reablation for patients with bleeding or pain. Logistic and Cox proportional hazard regression models were used in model development and validation of potential predictors of outcomes. RESULTS: The amenorrhea rate was 23% (95% confidence interval [CI] 19–28%) and the 5-year cumulative failure rate was 16% (95% CI 10–20%). Predictors of amenorrhea were age 45 years or older (adjusted odds ratio [aOR] 2.6, 95% CI 1.6–4.3); uterine length less than 9 cm (aOR 1.8, 95% CI 1.1–3.1); endometrial thickness less than 4 mm (aOR 2.7, 95% CI 1.2–6.3); and use of radio-frequency ablation instead of thermal balloon ablation (aOR 2.8, 95% CI 1.7–4.9). Predictors of treatment failure included age younger than 45 years (adjusted hazard ratio [aHR] 2.6, 95% CI 1.3–5.1); parity of 5 or greater (aHR 6.0, 95% CI 2.5–14.8); prior tubal ligation (aHR 2.2, 95% CI 1.2–4.0); and history of dysmenorrhea (aHR 3.7, 95% CI 1.6–8.5). After global endometrial ablation, 23 women (5.1%, 95% CI 3.2–7.5%) had pelvic pain, three (0.7%, 95% CI 0.1–1.9%) were pregnant, and none (95% CI 0–0.8%) had endometrial cancer. CONCLUSION: Population-derived rates and predictors of treatment outcomes after global endometrial ablation may help physicians offer optimal preprocedural patient counseling. LEVEL OF EVIDENCE: II

1 April 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
JBJamie N. Bakkum-Gamez
Jamie N. Bakkum-Gamez
NWNicolas Wentzensen
Nicolas Wentzensen
MMMatthew J. Maurer
Matthew J. Maurer
KHKieran M. Hawthorne
Kieran M. Hawthorne
JVJesse S. Voss
Jesse S. Voss
MSMark E. Sherman
Mark E. Sherman

1 March 2017 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
ZKZaraq Khan
Zaraq Khan
VZValentina Zanfagnin
Valentina Zanfagnin
SESherif A. El-Nashar
Sherif A. El-Nashar
AFAbimbola O. Famuyide
Abimbola O. Famuyide
GDGaurang S. Daftary
Gaurang S. Daftary
MHMatthew R. Hopkins
Matthew R. Hopkins